On the 10th (local time), the Vaccine and Biological Drug Advisory Committee (VRBPAC), an advisory body for the U.S. Food and Drug Administration (FDA), recommended approval for the emergency use of the Pfizer's coronavirus infection-19 (Corona 19) vaccine.
The Associated Press reported that VRBPAC deliberated on the agenda for urgent use of the Corona 19 vaccine applied by Pfizer-Bioentech, and then voted through a vote with 17 in favor, 4 dissent, and 1 abstention.
According to CNN Broadcast, the FDA is expected to approve emergency use for 10 or 11 days local time based on the recommendations of VRBPAC.
Although the FDA may allow the distribution of the vaccine, actual vaccination requires an additional decision of the Centers for Disease Control and Prevention (CD) Advisory Committee recommendations.
CNN predicted that a vote for the CDC's recommendations would take place on the afternoon of the 13th.
On the 17th, a VRBPAC meeting is scheduled to review the agenda for urgent use of vaccines requested by pharmaceutical company Modena.
(Photo = Getty Image Korea)